UTHR - UNITED THERAPEUTICS Corp

QQQ $ 623.13 $ 0.00 (0 %)

DIA $ 470.41 $ 0.00 (0 %)

SPY $ 676.00 $ 0.00 (0 %)

TLT $ 89.80 $ 0.00 (0 %)

GLD $ 364.93 $ 0.00 (0 %)

Previous Close

$ 438.66

Open

$ 441.39

Bid

$ 430.08 x 14

Ask

$ 438.84 x 5

Day's Range

-- - --

52 Week Range

$ 266.98 - $ 479.50

Volume

580,473

Average Volume

Market Cap

18.89B

Beta (5Y Monthly)

$ 0.56

PE Ratio (TTM)

$ 14.85

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	10-29-2025	09-30-2025	10-Q
2	07-30-2025	06-30-2025	10-Q
3	04-30-2025	03-31-2025	10-Q
4	02-26-2025	12-31-2024	10-K
5	10-30-2024	09-30-2024	10-Q
6	07-31-2024	06-30-2024	10-Q
7	05-01-2024	03-31-2024	10-Q
8	02-21-2024	12-31-2023	10-K
9	11-01-2023	09-30-2023	10-Q
10	08-02-2023	06-30-2023	10-Q
11	05-03-2023	03-31-2023	10-Q
12	02-22-2023	12-31-2022	10-K
13	11-02-2022	09-30-2022	10-Q
14	08-03-2022	06-30-2022	10-Q
15	05-04-2022	03-31-2022	10-Q
16	02-24-2022	12-31-2021	10-K
17	11-03-2021	09-30-2021	10-Q
18	08-04-2021	06-30-2021	10-Q
19	05-05-2021	03-31-2021	10-Q
20	02-24-2021	12-31-2020	10-K
21	10-28-2020	09-30-2020	10-Q
22	07-29-2020	06-30-2020	10-Q
23	04-29-2020	03-31-2020	10-Q
24	02-26-2020	12-31-2019	10-K
25	10-30-2019	09-30-2019	10-Q
26	07-31-2019	06-30-2019	10-Q
27	05-01-2019	03-31-2019	10-Q
28	02-27-2019	12-31-2018	10-K
29	10-31-2018	09-30-2018	10-Q
30	08-01-2018	06-30-2018	10-Q
31	05-02-2018	03-31-2018	10-Q
32	02-21-2018	12-31-2017	10-K
33	10-25-2017	09-30-2017	10-Q
34	07-27-2017	06-30-2017	10-Q
35	04-26-2017	03-31-2017	10-Q
36	02-22-2017	12-31-2016	10-K
37	10-27-2016	09-30-2016	10-Q
38	07-28-2016	06-30-2016	10-Q
39	04-28-2016	03-31-2016	10-Q
40	02-25-2016	12-31-2015	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

United Therapeutics Announced The First Cl...
11/03/2025 12:07:20

United Therapeutics' UKidney is an investigational xenokidney from a pig with 10 gene edits. Six human genes are added to t...

HC Wainwright & Co. Maintains Buy on Unite...
10/30/2025 16:23:42

HC Wainwright & Co. analyst Andrew S. Fein maintains United Therapeutics (NASDAQ:UTHR) with a Buy and raises the price t...

RBC Capital Maintains Outperform on United...
10/30/2025 15:43:02

RBC Capital analyst Lisa Walter maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price target fr...

Wells Fargo Maintains Equal-Weight on Unit...
10/30/2025 14:42:13

Wells Fargo analyst Benjamin Burnett maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price ta...

sp-500-tops-6900-ahead-fed-rate-move-gold-reclaims-4000-whats-moving-markets-wednesday

S&P 500 Tops 6,900 Ahead Fed Rate Move, Go...
10/29/2025 16:47:38

A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelle...

caterpillar-posts-upbeat-q3-results-joins-united-therapeutics-centene-fortive-and-other-big-stocks-moving-higher-on-wednesday

Caterpillar Posts Upbeat Q3 Results, Joins...
10/29/2025 14:46:09

Earnings Scheduled For October 29, 2025
10/29/2025 11:11:56

United Therapeutics Q3 2025 EPS $7.16 Beat...
10/29/2025 10:30:59

A Peek at United Therapeutics's Future Ear...
10/28/2025 18:01:55

If You Invested $100 In United Therapeutic...
10/21/2025 22:00:59

United Therapeutics to Present Latest Pulm...
10/13/2025 11:07:41

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced two presentations at the upcoming...

Morgan Stanley Maintains Equal-Weight on U...
10/10/2025 17:26:58

Morgan Stanley analyst Terence Flynn maintains United Therapeutics (NASDAQ:UTHR) with a Equal-Weight and raises the price ta...

UBS Maintains Buy on United Therapeutics, ...
09/29/2025 13:42:15

UBS analyst Ashwani Verma maintains United Therapeutics (NASDAQ: UTHR) with a Buy and raises the price target from $560 to $...

this-united-therapeutics-analyst-begins-coverage-on-a-bullish-note-here-are-top-5-initiations-for-friday

This United Therapeutics Analyst Begins Co...
09/26/2025 12:03:22

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

RBC Capital Initiates Coverage On United T...
09/26/2025 11:41:21

RBC Capital analyst Lisa Walter initiates coverage on United Therapeutics (NASDAQ: UTHR) with a Outperform rating and announ...

United Therapeutics To Review Positive TET...
09/19/2025 11:03:15

United Therapeutics To Showcase New Lung D...
09/12/2025 11:03:13

United Therapeutics Corporation (Nasdaq: UTHR), a public benefit corporation, today announced that recent research across its c...

Cantor Fitzgerald Maintains Overweight on ...
09/10/2025 13:04:57

Cantor Fitzgerald analyst Olivia Brayer maintains United Therapeutics (NASDAQ:UTHR) with a Overweight and raises the price t...

wayfair-united-therapeutics-and-ciena-are-among-the-top-10-large-cap-gainers-last-week-sep-1-sep5-are-the-others-in-your-portfolio-corrected

Wayfair, United Therapeutics, And Ciena Ar...
09/07/2025 14:30:00

These ten large-cap stocks were top performers last week. Are they a part of your portfolio?

Oppenheimer Maintains Outperform on United...
09/05/2025 14:34:58

Oppenheimer analyst Andreas Argyrides maintains United Therapeutics (NASDAQ:UTHR) with a Outperform and raises the price tar...